Denali Therapeutics
Neurology & CNS Therapeutics
Overview
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Visa sponsorship
6 ▼ 50%
H-1B filings in 12 months
2
Green card filings
$158k
Median offered salary
Who they sponsor
Biochemists and biophysicists
2
Other computer occupations
1
Microbiologists
1
In the register as Denali Therapeutics Inc., South San Francisco, CA (+1 more)
Other sponsors in the same field
AbbVie 
Genentech 
Biogen 
Alkermes
Alert me
US Department of Labor · latest filing Jun 29, 2026 · Visa details by country
Financials
Total raised
$499.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $499.7M | Details |
People
Carole Ho
Executive Officer
Ryan Watts
Executive Officer, Director
Alexander Schuth
Executive Officer
Vicki Sato
Director
Nancy Thornberry
Director
Peter Klein
Director
Marc Tessier-Lavigne
Director
Jay Flatley
Director
David Schenkein
Director
Erik Harris
Director
Steve Krognes
Director
Jennifer Cook
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Denali Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
1
Stack modernity
72/100
Languages
Python
R
Frameworks & libraries
Shiny
Developer tools
Git
Practices & domains
Mass Spectrometry
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
EcoR1 CapitalVia a fund
ARCH Venture PartnersVia a fund
F-Prime CapitalVia a fund
194 portfolio companies: AblePay Health, Arboretum LifeSciences, Inc., Arexera Therapeutics and 191 more
Eight RoadsVia a fund
GVVia a fund
569 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Is Denali Therapeutics (DNLI) Overvalued After Its FDA Approval?
Denali Therapeutics stock has delivered a 71.8% return over the past year, yet current valuation checks suggest the shares are trading at a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to an over
Read more
Report
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best AI driven biotech stocks to invest in. On May 22, Denali Therapeutics Inc. (NASDAQ:DNLI) halted its joint work with Biogen Inc. (NASDAQ:BIIB), around the development of BIIB122 for idiopathic Pa
Read more
Report
Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle Programs at the 2026 WORLDSymposium
SOUTH SAN FRANCISCO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that management will host a live webcast to review presentations on its Enzyme TransportVehicle (ETV) programs at the upcoming 22nd Annu
Read more
Report
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Denali Therapeutics.
Read more
Report
Denali Therapeutics announces HEALEY ALS trial regimen misses endpoints
Denali Therapeutics (DNLI) announced topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS Platform Trial evaluating eIF2B agonist DNL343 in the treatment of amyotrophic lateral sclerosis. The study did not meet the primary endpoint of
Read more
Report
Stifel Upgrades Denali Therapeutics (DNLI)
Fintel reports that on December 16, 2024, Stifel upgraded their outlook for Denali Therapeutics (NasdaqGS:DNLI) from Hold to Buy.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
1 posted in 90 days 1000-5000 est. staff